These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
377 results:

  • 1. SOXC Enhances NGN2-Mediated Reprogramming of Glioblastoma cells Into Neuron-Like cells by Modulating rhoa and RAC1/CDC42 Pathway Activity.
    Yang J; Zhu X; Wang F; Chen Z; Zhang Y; Chen J; Ni H; Zhang CL; Zhuge Q
    CNS Neurosci Ther; 2024 Oct; 30(10):e70075. PubMed ID: 39390804
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma cells.
    Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.
    Mekkan-Bouv Hez M; Derbey L; de Mestier L; Lorenzo D; Walter T; Perrier M; Cadiot G; Goichot B; Pracht M; Lièvre A; Coriat R; Valancot S; Guimbaud R; Carrere N; Bacoeur-Ouzillou O; Belleannée G; Smith D; Laboureau S; Hescot S; Julie C; Teissier MP; Thereaux J; Ferru A; Evrard C; Mathonnet M; Christou N
    Int J Surg; 2024 Jul; 110(7):4259-4265. PubMed ID: 38573078
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A combined opposite targeting of p110δ PI3K and rhoa abrogates skin cancer.
    Tzenaki N; Xenou L; Goulielmaki E; Tsapara A; Voudouri I; Antoniou A; Valianatos G; Tzardi M; De Bree E; Berdiaki A; Makrigiannakis A; Papakonstanti EA
    Commun Biol; 2024 Jan; 7(1):26. PubMed ID: 38182748
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma cells.
    Kolbe MR; Hohmann T; Hohmann U; Maronde E; Golbik R; Prell J; Illert J; Strauss C; Dehghani F
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998380
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Vasari-Based Features Nomogram to Predict the tumor-Infiltrating CD8+ T cell Levels in Glioblastoma.
    Xue C; Zhou Q; Zhang B; Ke X; Zhang P; Liu X; Li S; Deng J; Zhou J
    Acad Radiol; 2024 May; 31(5):2050-2060. PubMed ID: 37985291
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
    Zhang C; Shen C
    Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncogenic Gαq activates RhoJ through PDZ-RhoGEF.
    Cervantes-Villagrana RD; Color-Aparicio VM; Castillo-Kauil A; García-Jiménez I; Beltrán-Navarro YM; Reyes-Cruz G; Vázquez-Prado J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958718
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
    Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
    J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing rhoa/ROCK1 signaling.
    Zhou Y; Han Z; Zhao Z; Zhang J
    Environ Toxicol; 2024 Feb; 39(2):562-571. PubMed ID: 37449671
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Syx-rhoa-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.
    Lin WH; Feathers RW; Cooper LM; Lewis-Tuffin LJ; Chen J; Sarkaria JN; Anastasiadis PZ
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427593
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer.
    Xiao G; Cheng F; Yuan J; Lu W; Wang P; Fan H
    Oncol Res; 2022; 30(1):35-51. PubMed ID: 37304008
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miR-3174 Is a New tumor Suppressor MicroRNA That Inhibits Several tumor-Promoting Genes in Glioblastoma.
    Hanif F; Zhang Y; Dube C; Gibert MK; Saha S; Hudson K; Marcinkiewicz P; Kefas B; Guessous F; Abounader R
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298284
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gibbs process distinguishes survival and reveals contact-inhibition genes in Glioblastoma multiforme.
    Jahedi A; Kumar G; Kannan L; Agarwal T; Huse J; Bhat K; Kannan K
    PLoS One; 2023; 18(2):e0277176. PubMed ID: 36795646
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
    Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
    Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications.
    Dono A; El Achi H; Bundrant BE; Goli PS; Zhu P; Ozkizilkaya HI; Esquenazi Y; Ballester LY
    Cancer Biomark; 2023; 36(2):117-131. PubMed ID: 36530080
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.
    Yang Y; Wang S; Cai J; Liang J; Zhang Y; Xie Y; Luo F; Tang J; Gao Y; Shen S; Feng H; Li Y
    Cell Oncol (Dordr); 2023 Feb; 46(1):133-143. PubMed ID: 36520365
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma cells Downstream of Receptor Tyrosine Kinase Signalling.
    Almarán B; Ramis G; Fernández de Mattos S; Villalonga P
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496976
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.